MicroRNA-29c-3p inhibits osteosarcoma cell proliferation through targeting PIK3R3

H-Z Ma1, J Wang, J Shi

  • 1Department of Orthopedic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. mahuanzhi2006@163.com.

Abstract

Insights

MicroRNA-29c-3p is downregulated in osteosarcoma (OS) and linked to poor prognosis. This microRNA may suppress OS progression by regulating PIK3R3 expression, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs crucial for pathological regulation.
  • MicroRNA-29c-3p is recognized as a tumor suppressor gene in various cancers.
  • The specific role of microRNA-29c-3p in osteosarcoma (OS) progression remained uninvestigated.

Purpose of the Study:

  • To elucidate the function of microRNA-29c-3p in osteosarcoma.
  • To investigate the correlation between microRNA-29c-3p expression and clinical outcomes in OS patients.
  • To explore the underlying molecular mechanism of microRNA-29c-3p in OS progression.

Main Methods:

  • Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to assess microRNA-29c-3p levels in tumor and adjacent tissues, and OS cell lines.
  • Construction of microRNA-29c-3p knockdown and overexpression models in OS cells.
  • Cell proliferation (CCK-8) and invasion (Transwell) assays to evaluate cellular functions.
  • Western Blot and cell recovery experiments to explore the regulatory mechanism.

Main Results:

  • MicroRNA-29c-3p expression was significantly lower in OS tumor tissues compared to adjacent tissues.
  • Low microRNA-29c-3p expression correlated with increased distant metastasis and poorer overall survival in OS patients.
  • Knockdown of microRNA-29c-3p enhanced OS cell proliferation and invasion, while overexpression inhibited these processes.
  • MicroRNA-29c-3p was found to negatively regulate PIK3R3 expression, with a reciprocal correlation observed in OS tissues.

Conclusions:

  • MicroRNA-29c-3p is downregulated in osteosarcoma and associated with advanced disease and unfavorable prognosis.
  • MicroRNA-29c-3p exerts tumor-suppressive effects in osteosarcoma, potentially by inhibiting PIK3R3 expression.
  • Modulation of microRNA-29c-3p and its target PIK3R3 may represent a novel therapeutic strategy for osteosarcoma.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K